You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先聲藥業(2096.HK)漲近7%創歷史新高 首家提交甲苯磺酸艾多沙班片上市申請
格隆匯 06-08 10:51
格隆匯6月8日丨延續近期強勢,先聲藥業(2096.HK)盤中再度拉昇,一度漲超7%報11.76港元,創歷史新高價,市值超300億港元。該股自5月低點7.66港元上漲至今,不到一個月累漲53%。國家藥監局官網顯示,6月2日,先聲藥業提交甲苯磺酸艾多沙班片仿製藥上市申請。據悉,甲苯磺酸艾多沙班是一種選擇性Xa因子抑制劑,由日本第一三共研發,最早於2011年在日本獲批用於靜脈血栓栓塞,之後又有多個新適應症獲批,2020年全球銷售額1541億日元(約14億美元)。目前國內僅先聲藥業以仿製4類提交甲苯磺酸艾多沙班片上市申請,衝刺首仿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account